Literature DB >> 34191172

Design and Optimization of 3D-Printed Gastroretentive Floating Devices by Central Composite Design.

Thapakorn Charoenying1, Prasopchai Patrojanasophon1, Tanasait Ngawhirunpat1, Theerasak Rojanarata1, Prasert Akkaramongkolporn1, Praneet Opanasopit2.   

Abstract

This study aimed to optimize the size of capsule-shaped 3D-printed devices (CPD) using an experimental design by the response surface methodology to provide a gastroretentive drug delivery system (GRDDS) with optimal floating time. The CPD was fabricated using a fused deposition modeling (FDM) 3D printer. The central composite design was employed for the optimization of the devices. The morphology of the CPD was observed using a digital microscope and scanning electron microscope (SEM). The in vitro floating time and drug release were evaluated using a USP dissolution apparatus II. Appropriate total floating time (TFT) of the devices (more than 3 h) was obtained with the device's body, cap, and bottom thickness of 1.2, 1.8, and 2.9 mm, respectively. The release kinetics of the drug from the devices fitted well with zero-order kinetics. In conclusion, the optimization of CPD for GRDDS using the experimental design provided the devices with desirable floating time and ideal drug release characteristics.

Entities:  

Keywords:  central composite design; domperidone; experimental design; floating 3D-printed device; fused deposition modeling

Year:  2021        PMID: 34191172     DOI: 10.1208/s12249-021-02053-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

Review 1.  Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.

Authors:  Vivek K Pawar; Shaswat Kansal; Garima Garg; Rajendra Awasthi; Deepak Singodia; Giriraj T Kulkarni
Journal:  Drug Deliv       Date:  2010-10-20       Impact factor: 6.419

2.  Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.

Authors:  Alvaro Goyanes; Fabrizio Fina; Annalisa Martorana; Daniel Sedough; Simon Gaisford; Abdul W Basit
Journal:  Int J Pharm       Date:  2017-05-11       Impact factor: 5.875

3.  Fused-filament 3D printing (3DP) for fabrication of tablets.

Authors:  Alvaro Goyanes; Asma B M Buanz; Abdul W Basit; Simon Gaisford
Journal:  Int J Pharm       Date:  2014-09-30       Impact factor: 5.875

Review 4.  Overview on gastroretentive drug delivery systems for improving drug bioavailability.

Authors:  Carla M Lopes; Catarina Bettencourt; Alessandra Rossi; Francesca Buttini; Pedro Barata
Journal:  Int J Pharm       Date:  2016-05-09       Impact factor: 5.875

5.  Three-dimensional (3D)-printed devices composed of hydrophilic cap and hydrophobic body for improving buoyancy and gastric retention of domperidone tablets.

Authors:  Thapakorn Charoenying; Prasopchai Patrojanasophon; Tanasait Ngawhirunpat; Theerasak Rojanarata; Prasert Akkaramongkolporn; Praneet Opanasopit
Journal:  Eur J Pharm Sci       Date:  2020-09-16       Impact factor: 4.384

6.  3D printing of tablets using inkjet with UV photoinitiation.

Authors:  Elizabeth A Clark; Morgan R Alexander; Derek J Irvine; Clive J Roberts; Martin J Wallace; Sonja Sharpe; Jae Yoo; Richard J M Hague; Chris J Tuck; Ricky D Wildman
Journal:  Int J Pharm       Date:  2017-06-30       Impact factor: 5.875

7.  3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery.

Authors:  Sophia N Economidou; Cristiane Patricia Pissinato Pere; Andrew Reid; Md Jasim Uddin; James F C Windmill; Dimitrios A Lamprou; Dennis Douroumis
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-04-22

8.  Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone.

Authors:  Xuyu Chai; Hongyu Chai; Xiaoyu Wang; Jingjing Yang; Jin Li; Yan Zhao; Weimin Cai; Tao Tao; Xiaoqiang Xiang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

9.  Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs.

Authors:  Soyoung Shin; Tae Hwan Kim; Seok Won Jeong; Seung Eun Chung; Da Young Lee; Do-Hyung Kim; Beom Soo Shin
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

Review 10.  Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?

Authors:  Shrawani Lamichhane; Santosh Bashyal; Taekwang Keum; Gyubin Noh; Jo Eun Seo; Rakesh Bastola; Jaewoong Choi; Dong Hwan Sohn; Sangkil Lee
Journal:  Asian J Pharm Sci       Date:  2019-02-14       Impact factor: 6.598

View more
  2 in total

1.  Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®.

Authors:  Yoshihiro Omachi
Journal:  AAPS PharmSciTech       Date:  2022-06-08       Impact factor: 3.246

2.  Ameliorated Stomach Specific Floating Microspheres for Emerging Health Pathologies Using Polymeric Konjac Glucomannan-Based Domperidone.

Authors:  Jamal Moideen Muthu Mohamed; Nikita Mahajan; Mohamed El-Sherbiny; Shagufta Khan; Rasha Hamed Al-Serwi; Mohammed A Attia; Qamar Alsayed Altriny; Ahmed H Arbab
Journal:  Biomed Res Int       Date:  2022-07-13       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.